Iran's Razi Vaccine Institute among World’s Reputable Vaccine Manufacturers

The New Yor Times has issued "Coronavirus Vaccine Tracker" report, listing the names of 37 Reputable vaccine manufacturers in the world which have entered phase 2 clinical trial of Covid 19 vaccine. "On Feb. 7, Iran announced that it was launching a clinical trial of a second vaccine, known as Cov-Pars Razi and developed by the Razi Vaccine and Serum Research Institute. The vaccine contains fragments of coronavirus spike proteins and is delivered in three doses: two injections and one nasal spray. The researchers registered a Phase 2 trial on April 13."

It is also mentioned in this report that, Cuba’s Finlay Vaccine Institute developed a vaccine known as Soberana 2.  The Cuban institute Researchers began dosing trial participants in Iran on April 26. Cuban authorities expect results from the final trial by the end of May.

Also, The Australian company Vaxine developed a vaccine that combines viral proteins with an adjuvant that stimulates the immune system. A Phase 1 trial began in June 2020, and the company announced promising results in April 2021. In May, Vaxine said it would launch a Phase 2/3 trial in Iran within a few weeks. If the trial proved successful, the vaccine would be produced by the Iranian company CinnaGen.

Moreover, Shafa Pharmed Pars, an Iranian pharmaceutical company, developed a vaccine made of inactivated coronaviruses. Known as COVIran Barekat, it entered a Phase 1 trial at the end of December. COVIran Barekat is the first vaccine developed in Iran to go into clinical testing. CovIran Barekat began Phase 3 trials on April 25.

Further,ore, On March 16, Iran’s Ministry of Defence announced another vaccine made of inactivated coronaviruses. Known as Fakhravac, the vaccine is named after Mohsen Fakhrizadeh, Iran’s top nuclear scientist who was killed in November. The vaccine has completed a Phase 1 trial and will begin Phase 2 after Ramadan, the Tehran Times reported on May 5. - Mehr, New York Times